Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

BACKGROUND: We sought to develop a prognostic scoring system to aid in patient selection for immune checkpoint inhibitor (ICI) phase 1 clinical trials. METHODS: Clinical data from patients treated in phase 1 ICI clinical trials at MD Anderson (MDA) Center were analysed. Seventeen clinical factors we...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2018
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5886120/
https://ncbi.nlm.nih.gov/pubmed/29462132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.480
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki